Market Research Logo

Global Markets for Diabetes Therapeutics and Diagnostics

Global Markets for Diabetes Therapeutics and Diagnostics

The global diabetes market should reach $155 billion by 2021 from $125 billion in 2016 at a compound annual growth rate (CAGR) of 4.4%, from 2016 to 2021.

This report provides:
An overview of the global market for diabetes
Analyses of global market trends, with data from 2015, estimates for 2016, and projections of CAGRs through 2021.
Analysis of the devices and instruments used in the diagnosis and monitoring of diabetes
A close look at major forces contributing to the vigorous growth of the diabetes market
Evaluation of other factors influencing the market such as health care policies, demographics, and the wider economic environment
Discussion covering companies in the relevant pharmaceutical and medical industries through company profiles of many leading players in the field


This report discusses the implications of the above-mentioned trends, in the context of the current size and growth of the diabetes market, in global terms as well as by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided for the main drug and device categories, and breakdowns of the diabetes market are provided by country.

A comprehensive refresher section on diabetes is provided as an appendix.

CHAPTER 1 Introduction
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
SCOPE OF REPORT
MARKET ANALYSES AND FORECASTS
METHODOLOGY
INTENDED AUDIENCE
INFORMATION SOURCES
ANALYST'S CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
CHAPTER 2 SUMMARY
THE DIABETES MARKET
LEADING COMPANIES
SUMMARY TABLE GLOBAL DIABETES MARKET BY PRODUCT GROUP, THROUGH 2021 ($ BILLIONS)
SUMMARY FIGURE GLOBAL DIABETES MARKET BY PRODUCT GROUP, 2015-2021 ($ BILLIONS)
CHAPTER 3 OVERVIEW
DIABETES BASICS
STRUCTURE OF THE DIABETES MARKET
DRIVERS FOR GROWTH
Rising Prevalence
TABLE 1 GLOBAL AND REGIONAL DIABETES PREVALENCE CASES, 2015-2040 (MILLIONS)
New Technology
RATE OF MARKET GROWTH
CURRENT TREATMENT OF DIABETES
INSULIN
Insulin Administration Devices
ORAL ANTIDIABETIC DRUGS
MONITORING DEVICES FOR DIABETES
TABLE 2 GLOBAL DIABETES MARKET, 2015 ($ BILLIONS)
REGIONAL SEGMENTATION
TABLE 3 ADULT DIABETES MARKET BY REGION, 2015 ($ MILLIONS/%)
MARKET GROWTH
THE DIABETES INDUSTRY
PHARMACEUTICAL COMPANIES
MEDICAL DEVICE COMPANIES
CHAPTER 4 PRODUCTS AND SUPPLIERS
INSULIN
HISTORY
Bovine and Porcine Insulins
Humanized Insulin
COMPANIES SUPPLYING INSULIN
Eli Lilly
Sanofi
Novo Nordisk
Other Suppliers
Wockhardt Ltd. (India)
Biocon Ltd. (India)
Diosynth (the Netherlands)
TABLE 4 MAJOR BRANDS OF INSULIN
INSULIN DELIVERY
SYRINGES
INSULIN SYRINGE MANUFACTURERS
Becton Dickinson
Owen Mumford
Terumo
B. Braun
PENS
TABLE 5 INSULIN PENS
MANUFACTURERS OF INSULIN PENS
Novo Nordisk
Owen Mumford
Other Makers
INJECTORS
TABLE 6 INSULIN INJECTORS
INSULIN PUMPS
Defining an Insulin Pump
Infusion Sets
Candidates for Pump Therapy
COMPANIES SUPPLYING INSULIN PUMPS
Animas Corp.
Sooil Development Co.
Medtronic MiniMed
Roche Disetronic
Problems with Pumps or Users?
ORAL HYPOGLYCEMIC DRUGS
SULFONYLUREAS
TABLE 7 SULFONYLUREAS
BIGUANIDES
ALPHA-GLUCOSIDASE INHIBITOR
GLITAZONES
PRANDIAL GLUCOSE REGULATORS
GLP-1 ANALOGS; ALSO KNOWN AS INCRETIN MIMETICS
AMYLIN MIMETIC
TABLE 8 ORAL HYPOGLYCEMICS
DIAGNOSIS AND MONITORING
THE ROLE OF SELF-MONITORING
SMBG Frequency
BLOOD GLUCOSE MONITORING DEVICES AND SUPPLIERS
LANCETS
TABLE 9 GLOBAL SUPPLIERS OF BLOOD LANCETS
BLOOD SAMPLING DEVICES
Ascensia
Becton Dickinson
Cell Robotics
LifeScan
Roche Diagnostics
BLOOD GLUCOSE MONITORS
TABLE 10 MAJOR BLOOD GLUCOSE MONITOR SUPPLIERS AND BRANDS
77 Elektronica Kft
A. Menarini Diagnostics
Abbott Laboratories
Acon Laboratories Inc.
AgaMatrix Inc.
Apex Biotechnology Corp.
Arkray USA
Ascensia
Aventir Biotech LLC
Belbiosens
Diagnostic Devices Inc.
Eumed Biotechnology Co. Ltd.
HMD Bio Medical
GlucoPlus Inc.
Health & Life Co.
HemoCue AB
Home Diagnostics Inc.
Hypoguard
i-Sens Inc.
LifeScan Inc.
Medtronic MiniMed
National Diagnostic Products
Novabiomedical Corp.
Roche
TaiDoc Technology Corp.
US Diagnostics Inc.
GLUCOSE METER ACCURACY
OTHER TESTING APPROACHES
HEMOGLOBIN A1C
Hemoglobin A1c Meters
SOFTWARE AIDS TO DIABETES MONITORING
CHAPTER 5 NEW DEVELOPMENTS IN DIABETES
NEW INSULIN FORMULATIONS AND COMBINATIONS
NOVEL INSULIN DELIVERY TECHNOLOGY
Oral-Lyn
Oramed
Inhaled Insulin
IMPROVED ORAL ANTIDIABETIC DRUGS
NEW PRODUCTS NOW IN R&D OR RECENTLY APPROVED
Lixisenatide
Empagliflozin
Albiglutide
Dulaglutide
NEW DEVELOPMENTS IN GLUCOSE TESTING
CONTINUOUS GLUCOSE MONITORING (CGM)
Reimbursement
NON-INVASIVE MONITORING
ARTIFICIAL PANCREAS
Roche
Novo Nordisk/LifeScan
TABLE 11 DEVELOPMENT OF ARTIFICIAL PANCREAS: CURRENT STATUS
RADICAL APPROACHES
ALTERNATIVES TO INSULIN
Rituximab
IMMUNOTHERAPY
TRANSPLANTATION
CELL AND STEM CELL THERAPIES
GENE THERAPY
Gene Therapy Approaches for Expressing Insulin
Gene Therapy Approaches for Immunomodulation
Gene Therapy Approaches for Cell-Based Therapies
CHAPTER 6 THE GLOBAL DIABETES MARKET
MARKET COMPONENTS
MARKET SIZE
TABLE 12 GLOBAL DIABETES MARKET BY PRODUCT, 2016 ($ BILLIONS)
GROWTH
MARKET ANALYSIS BY PRODUCT CATEGORY
INSULINS AND INSULIN DELIVERY DEVICES
Major Suppliers
TABLE 13 GLOBAL SALES OF LEADING INSULIN PRODUCTS, 2013 ($ MILLIONS)
OTHER ANTIDIABETIC DRUGS
Major Suppliers
TABLE 14 SALES OF OTHER ANTIDIABETIC DRUGS, 2014 ($ MILLIONS)
INSULIN PUMPS
TABLE 15 GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2021 ($ MILLIONS)
MONITORING PRODUCTS
TABLE 16 LEADING SUPPLIERS OF GLUCOSE MONITORING PRODUCTS, 2015 ($ MILLIONS/%)
TRENDS
REGIONAL SEGMENTATION
TABLE 17 RISING PREVALENCE OF DIABETES BY REGION, 2015 AND 2021 (EST.) (MILLIONS OF CASES)
NATIONAL MARKETS
NORTH AMERICA
TABLE 18 DIABETES MARKET IN THE U.S. AND CANADA, THROUGH 2021 ($ BILLIONS)
SOUTH AND CENTRAL AMERICA
TABLE 19 DIABETES MARKET IN MEXICO AND BRAZIL, THROUGH 2021 ($ BILLIONS)
EUROPE
TABLE 20 DIABETES MARKET FOR MAJOR EUROPEAN ECONOMIES, THROUGH 2021 ($ BILLIONS)
ASIA
TABLE 21 DIABETES MARKET FOR MAJOR ASIAN COUNTRIES, THROUGH
2021 ($ BILLIONS)
NATIONAL MARKETS IN DETAIL
THE NORTH AND SOUTH AMERICAN MARKET
The U.S.
Vital Statistics
Health and Healthcare
The U.S. Pharmaceutical Market
TABLE 22 U.S. DIABETES MEDICATION MARKET, THROUGH 2021 ($ MILLIONS)
TABLE 23 U.S. DIABETES DEVICE MARKET, THROUGH 2021 ($ MILLIONS)
Canada
Vital Statistics
Health and Healthcare
The Pharmaceutical Market
Diabetes Market
TABLE 24 DIABETES MEDICATION MARKET IN CANADA, THROUGH 2021 ($ MILLIONS)
TABLE 25 DIABETES DEVICE MARKET IN CANADA, THROUGH 2021 ($ MILLIONS)
LATIN AMERICA
Brazil
Vital Statistics
Health and Healthcare
Pharmaceutical Market
TABLE 26 DIABETES MEDICATION MARKET IN BRAZIL, THROUGH 2021 ($ MILLIONS)
TABLE 27 DIABETES DEVICE MARKET IN BRAZIL, THROUGH 2021 ($ MILLIONS)
Mexico
Vital Statistics
Health and Healthcare
Pharmaceutical Market
Market Restraints
Diabetes Market
TABLE 28 DIABETES MEDICATION MARKET IN MEXICO, THROUGH 2021 ($ MILLIONS)
TABLE 29 DIABETES DEVICE MARKET IN MEXICO, THROUGH 2021 ($ BILLIONS)
ASIA
China
Vital Statistics
Health and Healthcare
Pharmaceutical Market
Domestic Industry
Importance of R&D
Challenges
Regulatory Changes
Diabetes Market
TABLE 30 DIABETES MEDICATION MARKET IN CHINA, THROUGH 2021 ($ BILLIONS)
TABLE 31 DIABETES DEVICE MARKET IN CHINA, THROUGH 2021 ($ BILLIONS)
India
Vital Statistics
Health and Healthcare
Growing Affluence - Changing Medical Needs
Regulatory Changes
Pharmaceutical Market
Demographic Factors
Pharmaceutical Industry
Patent Reform
Diabetes Market
TABLE 32 DIABETES MEDICATION MARKET IN INDIA, THROUGH 2021 ($ MILLIONS)
TABLE 33 DIABETES DEVICE MARKET IN INDIA, THROUGH 2021 ($ MILLIONS)
Japan
Vital Statistics
Health and Healthcare
Pharmaceutical Market
TABLE 34 TOP JAPANESE PHARMA COMPANIES, 2014 ($ MILLIONS/%)
Diabetes Market
TABLE 35 DIABETES MEDICATION MARKET IN JAPAN, THROUGH 2021 ($ MILLIONS)
TABLE 36 DIABETES DEVICE MARKET IN JAPAN, THROUGH 2021 ($ MILLIONS)
THE EUROPEAN MARKET
France
Vital Statistics
Health and Healthcare
Healthcare Provision
Pharmaceutical Market
TABLE 37 DIABETES MEDICATION MARKET IN FRANCE, THROUGH 2021 ($ MILLIONS)
TABLE 38 DIABETES DEVICE MARKET IN FRANCE, THROUGH 2021 ($ MILLIONS)
Germany
Vital Statistics
Health and Healthcare
Provision of Healthcare
Pharmaceutical Market
Price Controls
Diabetes Market
TABLE 39 DIABETES MEDICATION MARKET IN GERMANY, THROUGH 2021 ($ MILLIONS)
TABLE 40 DIABETES DEVICE MARKET IN GERMANY, THROUGH 2021 ($ MILLIONS)
Italy
Vital Statistics
Health and Healthcare
Healthcare System
Healthcare Provision
Pharmaceutical Market
Implications for Research
Diabetes Market
TABLE 41 DIABETES MEDICATION MARKET IN ITALY, THROUGH 2021 ($ MILLIONS)
TABLE 42 DIABETES DEVICE MARKET IN ITALY, THROUGH 2021 ($ MILLIONS)
Russia
Vital Statistics
Health and Healthcare
Healthcare Delivery
Pharmaceutical Market
Pharma 2020
Diabetes Market
TABLE 43 DIABETES MEDICATION MARKET IN RUSSIA, THROUGH 2021 ($ BILLIONS)
TABLE 44 DIABETES DEVICE MARKET IN RUSSIA, THROUGH 2021 ($ MILLIONS)
Spain
Vital Statistics
Health and Healthcare
Healthcare Provision
Pharmaceutical Services
Pharmaceutical Market
Diabetes Market
TABLE 45 DIABETES MEDICATION MARKET IN SPAIN, THROUGH 2021 ($ MILLIONS)
TABLE 46 DIABETES DEVICE MARKET IN SPAIN, THROUGH 2021 ($ MILLIONS)
United Kingdom
Vital Statistics
Health and Healthcare
Healthcare Provision
Private Sector Involvement
Pharmaceuticals
Pharmaceutical Market
Diabetes Market
TABLE 47 DIABETES MEDICATION MARKET IN THE U.K., THROUGH 2021 ($ MILLIONS)
TABLE 48 DIABETES DEVICE MARKET IN THE U.K., THROUGH 2021 ($ MILLIONS)
CHAPTER 7 COMPANY PROFILES
LEADING COMPANIES
A. MENARINI DIAGNOSTICS S.R.L.
ABBOTT LABORATORIES
Abbott Diabetes Care Inc.
ASCENSIA
BECTON DICKINSON
ELI LILLY AND CO.
Diabetes Products
GLAXO SMITHKLINE
Diabetes Products
JOHNSON & JOHNSON
Diabetes Products
MEDTRONIC
Diabetes Products
Pipeline
MERCK KGAA
Diabetes Product
MERCK & CO.
NOVARTIS PHARMA AG
Diabetes Products
NOVO NORDISK A/S
Diabetes Products
Pharmaceuticals
Pipeline
ROCHE
Diabetes Products
Blood Glucose Monitoring Systems
Diabetes Data Management
Insulin Pump Systems
Lancet Devices
Other
SANOFI
Diabetes Products
TAKEDA PHARMACEUTICAL CO. LTD.
OTHER COMPANIES
77 ELEKTRONIKA KFT.
AGAMATRIX INC.
ANIMAS CORP.
DEBIOTECH S.A.
INLIGHT SOLUTIONS INC.
LIFESCAN INC.
NIPRO CORP.
OWEN MUMFORD LTD.
PALCO LABS INC.
TERUMO CORP.
CHAPTER 8 APPENDIX I ABOUT DIABETES
BLOOD SUGAR REGULATION
INSULIN
TYPE 1 DIABETES
TYPE 2 DIABETES
GESTATIONAL DIABETES
OBESITY-RELATED TYPE 2 DIABETES IN CHILDREN
MATURE-ONSET DIABETES OF THE YOUNG (MODY)
OTHER DIABETIC STATES
LADA
PRE-DIABETES
DIAGNOSIS
GLUCOSE TESTS
OFFICIAL CRITERIA
DIFFERENTIAL DIAGNOSIS
Type 1 Diabetes
Type 2 Diabetes
CURRENT TREATMENT
Type 1 Diabetes
Type 2 Diabetes
Sulphonylureas
Biguanides
Alpha-glucosidase Inhibitors
Glitazones (Thiazolidinediones)
Prandial Glucose Regulators
Incretin Mimetics
DPP-4 Inhibitors
DIET
MONITORING DIABETES
Blood Sugar Control
THE DIABETES CONTROL AND COMPLICATIONS TRIAL
GLYCATED HEMOGLOBIN (HBA1C)
FRUCTOSAMINE
PREVALENCE OF DIABETES
TYPE 1
TYPE 2
DIABETIC COMPLICATIONS
RETINOPATHY
NEUROPATHY
NEPHROPATHY
INCREASED MORTALITY RISK
METABOLIC SYNDROME
CHAPTER 9 APPENDIX II GLOSSARY
TABLE 49 GLOSSARY OF TERMS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report